vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Life360, Inc. (LIF). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $146.0M, roughly 1.9× Life360, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 88.8%, a 7.5% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs 9.4%). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
ACAD vs LIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $146.0M |
| Net Profit | $273.6M | $129.7M |
| Gross Margin | 90.8% | 75.1% |
| Operating Margin | 6.1% | 6.1% |
| Net Margin | 96.3% | 88.8% |
| Revenue YoY | 9.4% | 26.4% |
| Net Profit YoY | 90.3% | 1425.9% |
| EPS (diluted) | $1.61 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $146.0M | ||
| Q3 25 | $278.6M | $124.5M | ||
| Q2 25 | $264.6M | $115.4M | ||
| Q1 25 | $244.3M | $103.6M | ||
| Q4 24 | $259.6M | $115.5M | ||
| Q3 24 | $250.4M | $92.9M | ||
| Q2 24 | $242.0M | $84.9M | ||
| Q1 24 | $205.8M | $78.2M |
| Q4 25 | $273.6M | $129.7M | ||
| Q3 25 | $71.8M | $9.8M | ||
| Q2 25 | $26.7M | $7.0M | ||
| Q1 25 | $19.0M | $4.4M | ||
| Q4 24 | $143.7M | $8.5M | ||
| Q3 24 | $32.8M | $7.7M | ||
| Q2 24 | $33.4M | $-11.0M | ||
| Q1 24 | $16.6M | $-9.8M |
| Q4 25 | 90.8% | 75.1% | ||
| Q3 25 | 92.2% | 78.0% | ||
| Q2 25 | 92.2% | 78.4% | ||
| Q1 25 | 91.7% | 80.6% | ||
| Q4 24 | 91.6% | 74.0% | ||
| Q3 24 | 92.5% | 75.4% | ||
| Q2 24 | 92.5% | 75.0% | ||
| Q1 24 | 88.8% | 76.7% |
| Q4 25 | 6.1% | 6.1% | ||
| Q3 25 | 12.8% | 4.6% | ||
| Q2 25 | 12.2% | 1.7% | ||
| Q1 25 | 7.9% | 2.1% | ||
| Q4 24 | 59.1% | 4.9% | ||
| Q3 24 | 12.6% | -5.3% | ||
| Q2 24 | 12.6% | -2.8% | ||
| Q1 24 | 7.4% | -8.2% |
| Q4 25 | 96.3% | 88.8% | ||
| Q3 25 | 25.8% | 7.9% | ||
| Q2 25 | 10.1% | 6.1% | ||
| Q1 25 | 7.8% | 4.2% | ||
| Q4 24 | 55.4% | 7.4% | ||
| Q3 24 | 13.1% | 8.3% | ||
| Q2 24 | 13.8% | -12.9% | ||
| Q1 24 | 8.0% | -12.5% |
| Q4 25 | $1.61 | $1.53 | ||
| Q3 25 | $0.42 | $0.11 | ||
| Q2 25 | $0.16 | $0.08 | ||
| Q1 25 | $0.11 | $0.05 | ||
| Q4 24 | $0.86 | $0.14 | ||
| Q3 24 | $0.20 | $0.09 | ||
| Q2 24 | $0.20 | $-0.15 | ||
| Q1 24 | $0.10 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $494.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $548.2M |
| Total Assets | $1.6B | $959.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $494.3M | ||
| Q3 25 | $258.0M | $455.7M | ||
| Q2 25 | $253.6M | $432.7M | ||
| Q1 25 | $217.7M | $168.9M | ||
| Q4 24 | $319.6M | $159.2M | ||
| Q3 24 | $155.1M | $159.0M | ||
| Q2 24 | $177.1M | $160.8M | ||
| Q1 24 | $204.7M | $73.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $1.2B | $548.2M | ||
| Q3 25 | $917.3M | $391.4M | ||
| Q2 25 | $822.4M | $366.7M | ||
| Q1 25 | $765.2M | $376.3M | ||
| Q4 24 | $732.8M | $358.5M | ||
| Q3 24 | $577.2M | $339.7M | ||
| Q2 24 | $516.7M | $326.7M | ||
| Q1 24 | $464.0M | $239.8M |
| Q4 25 | $1.6B | $959.7M | ||
| Q3 25 | $1.3B | $787.5M | ||
| Q2 25 | $1.2B | $753.6M | ||
| Q1 25 | $1.1B | $455.4M | ||
| Q4 24 | $1.2B | $441.6M | ||
| Q3 24 | $976.9M | $427.4M | ||
| Q2 24 | $914.1M | $405.9M | ||
| Q1 24 | $855.1M | $318.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $36.8M |
| Free Cash FlowOCF − Capex | — | $36.6M |
| FCF MarginFCF / Revenue | — | 25.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | -0.18× | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $36.8M | ||
| Q3 25 | $74.3M | $26.4M | ||
| Q2 25 | $64.0M | $13.3M | ||
| Q1 25 | $20.3M | $12.1M | ||
| Q4 24 | $40.4M | $12.3M | ||
| Q3 24 | $63.2M | $6.3M | ||
| Q2 24 | $25.0M | $3.3M | ||
| Q1 24 | $29.1M | $10.7M |
| Q4 25 | — | $36.6M | ||
| Q3 25 | $73.9M | $25.6M | ||
| Q2 25 | — | $12.7M | ||
| Q1 25 | — | $11.9M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $63.2M | $6.3M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | — | — |
| Q4 25 | — | 25.1% | ||
| Q3 25 | 26.5% | 20.6% | ||
| Q2 25 | — | 11.0% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | 25.2% | 6.8% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 0.1% | 0.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | -0.18× | 0.28× | ||
| Q3 25 | 1.03× | 2.70× | ||
| Q2 25 | 2.40× | 1.90× | ||
| Q1 25 | 1.07× | 2.75× | ||
| Q4 24 | 0.28× | 1.45× | ||
| Q3 24 | 1.93× | 0.83× | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
LIF
Segment breakdown not available.
